Viewing Study NCT05593094

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:28 AM
Ignite Modification Date: 2026-03-22 @ 3:40 PM
Study NCT ID: NCT05593094
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-28
First Post: 2022-10-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors
Sponsor: Hoffmann-La Roche
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors View
None HER2-positive Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase 1 View
None Advanced Solid Tumors View
None HER2 postive View
None Brain metastases View
None Herceptin View
None Perjeta View
None PHESGO View
None First Line View
None 1st Line View